Climate Change Countermeasures
Mochida Pharmaceutical Group has set a target of reducing carbon emissions by 46% from FY2013 levels by FY2030, and reaching carbon neutrality by 2050. We are working to reduce CO2 emissions through initiatives such as improvement of energy efficiency across Mochida Pharmaceutical Group as a whole, to fulfill our social responsibility and help realize a carbon-free society. As in the previous year, we made progress replacing our commercial fleet with hybrid vehicles and worked to reduce CO2 emissions at all sites through the installation of more efficient air conditioning systems and the systematic adoption of carbon free electricity. Meanwhile, the headquarters building (which began operating out from September 2022) received a top-level BELS 5-star rating in the "Building-Housing Energy-efficiency Labeling System (BELS)" evaluation and was certified as "ZEB Ready" which means the building achieves energy savings of greater than 50%, thanks to an environmentally friendly design which uses site conditions to reduce the environmental impact of air conditioning and deploys energy efficient lighting and air-conditioning systems. Furthermore, in an initiative that utilizes the land we own to reduce our environmental impact, we plan to install solar panels for renewable energy generation at our Fujieda site.
[ Trend of CO2 Emissions ](t-CO2)
Sites covered:
Head Office, Gotemba site, Fujieda site and every other business site of Mochida Pharmaceutical Co., Ltd., Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd., and Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd.
CO2 emissions:
Total amount of energy-related CO2 emissions from fuel and electricity consumption
[ Trend of Energy Consumption ] (terajoules)
Sites covered:
Head Office, Gotemba site, Fujieda site and every other business site of Mochida Pharmaceutical Co., Ltd., Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd., and Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd.
Energy consumption:
Total consumption of all types of energy including electricity, fuel oil (until FY2019), gasoline, LNG and city gas
Gas-fired once-through boilers (Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.)
Heat pumps (Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.)
Reduction and Recycling of Waste
Mochida Pharmaceutical Group is working on the reduction and recycling of waste generated in its business activities. We promote the 3Rs (Reduce, Reuse, Recycle) and are committed to reducing the amount of waste we generate to 582 tons or lower by FY2030, increasing our waste recycling rate to 98% or higher, and maintaining a plastic waste recycling rate of 65% or higher.
[ Trends of Amount of Waste Generated and Recycling Rate ] (tons)
Sites covered:
Head Office, Gotemba site, Fujieda site and every other business site of Mochida Pharmaceutical Co., Ltd., Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd., and Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd.*
Recycling amount: Total amount of waste generated which was the subject of reuse, material recycling or thermal recycling (heat recovery and residue use)
* Data from April 2020 to September 2022 excludes Head Office of Mochida Pharmaceutical Co., Ltd.
Water Resources and Water Quality
High quality water is essential for Mochida Pharmaceutical Group's business activities, especially its R&D and manufacturing activities. Mochida Pharmaceutical Group strives to comply with laws and regulations and water standards agreed with each local government and is working to use water resources efficiently and to manage wastewater properly. In addition, Mochida Pharmaceutical Plant Co., Ltd. has completely replaced the below ground drainage system with an above ground drainage system at its Head Office Plant to prevent soil contamination due to leakages. To ensure business continuity going forward, we will make effective use of finite water resources by managing our water consumption and amount of wastewater on an ongoing basis.
[ Trends of Water Consumption and Amount of Wastewater ] (thousand m3)
Sites covered:
Head Office, Gotemba site, Fujieda site and every other business site of Mochida Pharmaceutical Co., Ltd., Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd., and Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd. *
Water consumption:
Total of extraction of groundwater and water purchased from public water supply
* Data from April 2020 to September 2022 excludes Head Office of Mochida Pharmaceutical Co., Ltd.
Prevention of Air Pollution
In efforts to prevent air pollution, Mochida Pharmaceutical Group completed the switch from fuel oil to LNG and city gas in FY2019. This move reduced the Group's particulate matter, oxides of nitrogen and sulfur (NOx and SOx) emissions to zero. We will continue striving to comply with laws and regulations and the standards agreed with each local government.
Proper Management of Chemical Substances
The Gotemba and Fujieda sites, the Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd., and the Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd. fully recognize the impact that the chemical substances needed to develop and manufacture pharmaceuticals and healthcare products have on human health and the ecosystem, and they use and manage chemical substances properly.